Aurinia Pharmaceuticals Inc (AUPH)
8.35
+0.08
(+0.97%)
USD |
NASDAQ |
Sep 22, 16:00
8.34
-0.01
(-0.12%)
After-Hours: 20:00
Aurinia Pharmaceuticals Revenue (TTM): 160.12M for June 30, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| June 30, 2023 | 160.12M |
| March 31, 2023 | 146.81M |
| December 31, 2022 | 134.03M |
| September 30, 2022 | 129.00M |
| June 30, 2022 | 87.89M |
| March 31, 2022 | 66.32M |
| December 31, 2021 | 45.60M |
| September 30, 2021 | 72.23M |
| June 30, 2021 | 57.59M |
| March 31, 2021 | 51.00M |
| December 31, 2020 | 50.12M |
| September 30, 2020 | 0.117M |
| June 30, 2020 | 0.318M |
| March 31, 2020 | 0.318M |
| December 31, 2019 | 0.318M |
| September 30, 2019 | 0.318M |
| June 30, 2019 | 0.463M |
| March 31, 2019 | 0.463M |
| December 31, 2018 | 0.463M |
| September 30, 2018 | 0.464M |
| June 30, 2018 | 0.118M |
| March 31, 2018 | 0.418M |
| December 31, 2017 | 0.418M |
| September 30, 2017 | 0.418M |
| June 30, 2017 | 0.42M |
| Date | Value |
|---|---|
| March 31, 2017 | 0.146M |
| December 31, 2016 | 0.173M |
| September 30, 2016 | 0.20M |
| June 30, 2016 | 0.226M |
| March 31, 2016 | 0.23M |
| December 31, 2015 | 0.235M |
| September 30, 2015 | 0.246M |
| June 30, 2015 | 0.261M |
| March 31, 2015 | 0.273M |
| December 31, 2014 | 0.278M |
| September 30, 2014 | 0.922M |
| June 30, 2014 | 0.934M |
| March 31, 2014 | 0.948M |
| December 31, 2013 | 0.969M |
| September 30, 2013 | 0.3432M |
| June 30, 2013 | 0.3466M |
| March 31, 2013 | 0.3501M |
| December 31, 2012 | 6.075M |
| September 30, 2012 | 6.109M |
| June 30, 2012 | 6.557M |
| March 31, 2012 | 6.621M |
| December 31, 2011 | 0.9455M |
| September 30, 2011 | 1.123M |
| June 30, 2011 | 0.8521M |
| March 31, 2011 | 2.113M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.117M
Minimum
Sep 2020
160.12M
Maximum
Jun 2023
50.20M
Average
47.86M
Median
Revenue (TTM) Benchmarks
| Acasti Pharma Inc | -- |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | 0.3408M |
| Liminal Biosciences Inc | 0.3635M |
| Xenon Pharmaceuticals Inc | -- |